PLRX
Price
$11.60
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
25 days until earnings call
RCUS
Price
$17.10
Change
-$0.00 (-0.00%)
Updated
Oct 10 closing price
25 days until earnings call
Ad is loading...

PLRX vs RCUS

Header iconPLRX vs RCUS Comparison
Open Charts PLRX vs RCUSBanner chart's image
Pliant Therapeutics
Price$11.60
Change-$0.00 (-0.00%)
Volume$270.08K
CapitalizationN/A
Arcus Biosciences
Price$17.10
Change-$0.00 (-0.00%)
Volume$1.16M
CapitalizationN/A
View a ticker or compare two or three
PLRX vs RCUS Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PLRX vs. RCUS commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Buy and RCUS is a StrongBuy.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (PLRX: $11.60 vs. RCUS: $17.10)
Brand notoriety: PLRX and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 77% vs. RCUS: 190%
Market capitalization -- PLRX: $681.58M vs. RCUS: $1.41B
PLRX [@Biotechnology] is valued at $681.58M. RCUS’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 6 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • PLRX’s TA Score: 6 bullish, 4 bearish.
  • RCUS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than RCUS.

Price Growth

PLRX (@Biotechnology) experienced а +4.32% price change this week, while RCUS (@Biotechnology) price change was +11.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

PLRX is expected to report earnings on Mar 04, 2025.

RCUS is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($1.41B) has a higher market cap than PLRX($682M). RCUS YTD gains are higher at: -10.471 vs. PLRX (-35.947). PLRX has higher annual earnings (EBITDA): -181.41M vs. RCUS (-235M). RCUS has more cash in the bank: 969M vs. PLRX (437M). RCUS has less debt than PLRX: RCUS (11M) vs PLRX (60.2M). RCUS has higher revenues than PLRX: RCUS (247M) vs PLRX (0).
PLRXRCUSPLRX / RCUS
Capitalization682M1.41B48%
EBITDA-181.41M-235M77%
Gain YTD-35.947-10.471343%
P/E RatioN/AN/A-
Revenue0247M-
Total Cash437M969M45%
Total Debt60.2M11M547%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXRCUS
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 9 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME20.910.41
+2.00%
GameStop Corp
SPY576.13-1.01
-0.18%
SPDR® S&P 500® ETF Trust
AAPL229.04-0.50
-0.22%
Apple
BTC.X60274.500000-307.601560
-0.51%
Bitcoin cryptocurrency
TSLA238.77-2.28
-0.95%
Tesla

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+1.05%
NTLA - PLRX
54%
Loosely correlated
+0.79%
INZY - PLRX
53%
Loosely correlated
-3.52%
BEAM - PLRX
52%
Loosely correlated
-1.75%
PRME - PLRX
51%
Loosely correlated
+0.56%
RCKT - PLRX
50%
Loosely correlated
-0.48%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with NTLA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-3.61%
NTLA - RCUS
53%
Loosely correlated
+0.79%
PRME - RCUS
51%
Loosely correlated
+0.56%
OCUL - RCUS
50%
Loosely correlated
-0.86%
DNLI - RCUS
50%
Loosely correlated
-2.94%
SNDX - RCUS
50%
Loosely correlated
-0.66%
More